Aquatic Capital Management LLC Intra Cellular Therapies, Inc. Transaction History

Aquatic Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$64.37 - $75.65 $321,850 - $378,250	-5,000 Reduced 94.34%	300 $20,000
Q4 2023 Feb 14, 2024	SELL	$46.37 - $73.65 $783,653 - $1.24 Million	-16,900 Reduced 76.13%	5,300 $380,000
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $395,884 - $487,159	7,600 Added 52.05%	22,200 $1.16 Million
Q2 2023 Aug 14, 2023	BUY	$54.67 - $66.44 $125,741 - $152,812	2,300 Added 18.7%	14,600 $924,000
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $538,740 - $700,977	12,300 New	12,300 $666,000
Q2 2022 Aug 15, 2022	SELL	$43.0 - $65.64 $51,600 - $78,768	-1,200 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$38.74 - $62.09 $112,346 - $180,061	-2,900 Reduced 70.73%	1,200 $73,000
Q4 2021 Feb 14, 2022	BUY	$35.2 - $53.42 $144,320 - $219,022	4,100 New	4,100 $215,000

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.85B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.